Merck’s Gardasil vaccine for cervical cancer isn’t cheap — it’s a three-shot series that costs about $360. Whether it’s worth the money depends on several variables, suggests an analysis in this week’s New England Journal of Medicine.
Assuming the vaccine provides lifelong immunity, vaccinating girls at age 12 costs $43,600 per quality-adjusted life-year (QALY) gained — [...]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment